ALIMERA SCIENCES
Alimera Sciences is a pharmaceutical company that specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. They are focused on diseases affecting the back of the eye, or retina because these diseases are not well treated with current therapies and will affect millions of people in their aging populations.
ALIMERA SCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
2003-01-01
Address:
Alpharetta, Georgia, United States
Country:
United States
Website Url:
http://www.alimerasciences.com
Total Employee:
51+
Status:
Active
Contact:
+1 678 990 5740
Email Addresses:
[email protected]
Total Funding:
304.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ocumension Therapeutics
Ocumension Therapeutics investment in Post-IPO Equity - Alimera Sciences
Federal Government
Federal Government investment in Post-IPO Debt - Alimera Sciences
Deerfield
Deerfield investment in Post-IPO Equity - Alimera Sciences
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Alimera Sciences
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Alimera Sciences
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Alimera Sciences
Palo Alto Investors
Palo Alto Investors investment in Post-IPO Equity - Alimera Sciences
Domain Associates
Domain Associates investment in Series C - Alimera Sciences
Polaris Partners
Polaris Partners investment in Series C - Alimera Sciences
Intersouth Partners
Intersouth Partners investment in Series C - Alimera Sciences
Official Site Inspections
http://www.alimerasciences.com Semrush global rank: 4.97 M Semrush visits lastest month: 1.71 K
- Host name: cloudhost-63201.uk-south-2.nxcli.net
- IP address: 165.84.219.3
- Location: Byfleet United Kingdom
- Latitude: 51.3388
- Longitude: -0.474
- Timezone: Europe/London
- Postal: KT14